Literature DB >> 15002023

Involvement of bone marrow-derived stem and progenitor cells in the pathogenesis of pterygium.

J Ye1, Y S Song, S H Kang, K Yao, J C Kim.   

Abstract

AIMS: To evaluate the involvement of multipotential stem and progenitor cells in the pathogenesis of pterygium.
METHODS: Paraffin-embedded and snap-frozen primary pterygium (n = 10) were serially sectioned and analysed immunohistochemically to determine the expression level of AC133 (marker for the primitive haematopoietic progenitors), CD34 (marker for the haematopoietic progenitor cells and endothelium), c-Kit (marker for haematopoietic and stromal progenitor cells), and STRO-1 (a differentiation antigen present on bone marrow fibroblast cells and on various nonhaematopoietic progenitor cells).
RESULTS: In all the primary pterygium, immunoreactivity of AC133 and STRO-1 was found in some of the epithelial and stromal cells, CD34 was observed in the vascular endothelium, and some scattered ovoidal cells were found in the subepithelial connective tissue. C-Kit was expressed mainly in the basal epithelium of the head portions, and some spindle-shaped stromal cells. There is no immunoreactivity of AC133, c-Kit, and STRO-1 in normal conjunctiva, whereas CD34 was mildly stained with vessel wall.
CONCLUSION: Multipotential stem and progenitor cells may be involved in the pathogenesis of pterygium through its differentiation into fibroblasts and vascular endothelial cells.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15002023     DOI: 10.1038/sj.eye.6701346

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN: 0950-222X            Impact factor:   3.775


  9 in total

1.  Temporary amniotic membrane patch for the treatment of primary pterygium: mechanisms of reducing the recurrence rate.

Authors:  Juan Ye; Koung Hoon Kook; Ke Yao
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2005-09-17       Impact factor: 3.117

2.  A new role of substance P as an injury-inducible messenger for mobilization of CD29(+) stromal-like cells.

Authors:  Hyun Sook Hong; Jungsun Lee; EunAh Lee; Young Sam Kwon; Eunkyung Lee; Woosung Ahn; Mei Hua Jiang; Jae Chan Kim; Youngsook Son
Journal:  Nat Med       Date:  2009-03-08       Impact factor: 53.440

Review 3.  Recent progress on tissue-resident adult stem cell biology and their therapeutic implications.

Authors:  Murielle Mimeault; Surinder K Batra
Journal:  Stem Cell Rev       Date:  2008       Impact factor: 5.739

4.  Progenitor cells in healing after pterygium excision.

Authors:  Jeong Kyu Lee; Jae Chan Kim
Journal:  Yonsei Med J       Date:  2007-02-28       Impact factor: 2.759

Review 5.  Pterygium: an update on pathophysiology, clinical features, and management.

Authors:  Toktam Shahraki; Amir Arabi; Sepehr Feizi
Journal:  Ther Adv Ophthalmol       Date:  2021-05-31

6.  Identification of three prominin homologs and characterization of their messenger RNA expression in Xenopus laevis tissues.

Authors:  Zhou Han; David S Papermaster
Journal:  Mol Vis       Date:  2011-05-25       Impact factor: 2.367

7.  Cyclooxygenase-2-expressing macrophages in human pterygium co-express vascular endothelial growth factor.

Authors:  Choul Yong Park; Jong Sun Choi; Sung Jun Lee; Sang Won Hwang; Eo-Jin Kim; Roy S Chuck
Journal:  Mol Vis       Date:  2011-12-29       Impact factor: 2.367

Review 8.  How to minimize pterygium recurrence rates: clinical perspectives.

Authors:  Raffaele Nuzzi; Federico Tridico
Journal:  Clin Ophthalmol       Date:  2018-11-19

9.  Immunophenotypic characterization of telocyte-like cells in pterygium.

Authors:  Cristina Maxia; Daniela Murtas; Michela Isola; Roberto Tamma; Ignazio Zucca; Franca Piras; Domenico Ribatti; Andrea Diana; Maria Teresa Perra
Journal:  Mol Vis       Date:  2018-12-29       Impact factor: 2.367

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.